Browsing eNauka
Browsing by Author Cho, BC
Showing results 1 to 2 of 2
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2022 | A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829) | Cho, BC; ...; Zaric, Bojan   | Conference Paper | Mp. category will be shown later |
| 2021 | Updated analysis and patient-reported outcomes (PROs) from CITYSCAPE: A randomised, double-blind, phase II study of the anti-TIGIT antibody tiragolumab plus atezolizumab (TA) versus placebo plus atezolizumab (PA) as first-line treatment for PD-L1+NSCLC | Cho, BC; ...; Secen, Nevena M; ...; (broj, koautora 19) | Conference Paper | Mp. category will be shown later |